News | March 17, 2025
Strides Pharma global to acquire 100% stake in Amextel
Amexel aims to generate revenue through facilitation services and a profit-sharing model linked to the commercialization of products
Amexel aims to generate revenue through facilitation services and a profit-sharing model linked to the commercialization of products
These appointments align with the group’s philosophy of having a strong and independent board with exceptional industry experts, ensuring strategic guidance and effective governance
This achievement underscores the company’s steadfast commitment to sustainability, corporate responsibility, and ESG excellence
This termination of Agreement will not have any significant impact on the company and/or its subsidiaries or its financials
Metropolis Clinical Pathology will acquire and operate all laboratories and collection centers of Scientific Pathology in Agra and neighbouring towns through a slump sale transaction
Revenue from operations also dropped 8.3 per cent at Rs. 133.5 crore in Q3 FY25
Dr. Prabhavathi brings over 14 years of unparalleled experience in pediatrics and a specialized focus on neurodevelopmental disorders
Peter Bains has over three decades of experience in the biotech and pharmaceutical industry
Itolizumab achieved key secondary endpoint of endoscopic remission of 16.7% compared to 16.7% for adalimumab and 6.7% for placebo
Consolidated manufacturing volumes for Q3 FY25 remained stable at 132,187 KL, while for 9M FY25 it stood at 372,505 KL
Subscribe To Our Newsletter & Stay Updated
